Sandesh Mahatme, EVP, CFO & CBO at Sarepta Therapeutics, Inc. (SRPT), sold 21,198 shares at $130.72 ($2.8M) on 2019-01-31, disclosed to the SEC on 2019-02-01.
Open-market sale of $2.8M SRPT by EVP, CFO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2019-02-01 | $8.5M | — | Filing → |
| SRPT | SELL | 2018-10-26 | $27.5M | — | Filing → |
| SRPT | SELL | 2017-07-21 | $2.0M | — | Filing → |